Pharma Italia Integration And SGEL Libros Acquisition Drive Growth, But Declining Tobacco Sales Pose Risks

Shared on09 Apr 25
Fair value Decreased 3.74%

Shared on02 Apr 25
Fair value Increased 0.67%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 2.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.